Related Experiment Video
Updated: Mar 7, 2026
13:34
Assessment of Memory Function in Pilocarpine-induced Epileptic Mice
Published on: June 4, 2020
8.9K
[Alzheimer's disease and epilepsy]
R Haussmann1, T Mayer2, W Schrempf3
1Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland. robert.haussmann@uniklinikum-dresden.de.
Der Nervenarzt
|February 12, 2017
Summary
Epileptic seizures in Alzheimer's disease are often missed but negatively impact daily living and cognition. Effective treatment with anticonvulsants is possible, though careful monitoring for side effects and drug interactions is crucial.
Area of Science:
- Neurology
- Neuroscience
- Geriatric Medicine
Background:
- Epileptic seizures in Alzheimer's disease (AD) are underdiagnosed due to atypical symptoms.
- Seizures significantly worsen cognitive function and daily living activities in AD patients.
- Current understanding of the link between AD and epilepsy relies heavily on animal models.
Purpose of the Study:
- To highlight the clinical underestimation of seizures in Alzheimer's disease.
- To emphasize the negative impact of seizures on Alzheimer's patients.
- To review current therapeutic approaches and challenges in managing epilepsy in AD.
Main Methods:
- Review of existing clinical data and research on epilepsy in Alzheimer's disease.
- Analysis of reported incidences and prevalences.
- Evaluation of treatment responses and tolerability of anticonvulsants.
Main Results:
- Data on seizure incidence and prevalence in AD show significant variability and underestimation.
- Clinical studies indicate a positive response to anticonvulsant therapy.
- Newer anticonvulsant agents demonstrate good tolerability in this patient population.
Conclusions:
- Accurate diagnosis and treatment of epileptic seizures are vital for improving quality of life in Alzheimer's patients.
- Anticonvulsant therapy is generally effective and well-tolerated, but requires careful monitoring.
- Further research is needed to clarify pathogenetic mechanisms and risk factors.
More Related Videos
Related Concept Videos
01:24Epilepsy and Seizures: Overview
1.5K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
01:14Antiepileptic Drugs: Glutamate Antagonists
1.1K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K
01:13Seizures: Classification
1.9K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.9K
01:17Antiepileptic Drugs: Calcium Channel Blockers
1.5K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.5K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.5K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.5K
01:20Antiepileptic Drugs: Potassium Channel Activators
878
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
878